Eritrea vs Latin America and the Caribbean: Mortality rate attributed to cardiovascular disease, cancer, diabetes
Eritrea
27.3
in 2021
Latin America and the Caribbean
14.7
in 2021
Eritrea rank
16th
Latin America and the Caribbean rank
17th
Mortality rate attributed to cardiovascular disease, cancer, diabetes over time
- Eritrea
- Latin America and the Caribbean
How they compare
Eritrea currently reports 27.3 against 14.7 in Latin America and the Caribbean, a difference of 12.6.
That makes Eritrea's figure about 1.9 times Latin America and the Caribbean's.
Across all 7 years both countries report, Eritrea has been ahead every year.
Eritrea ranks 16th and Latin America and the Caribbean ranks 17th of 197 countries.
Eritrea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | Latin America and the Caribbean | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.2 | 17.8 | 14.4 | Eritrea |
| 2010s | 28.57 | 15.4 | 13.17 | Eritrea |
| 2020s | 27.6 | 14.85 | 12.75 | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality rate attributed to cardiovascular disease, cancer, diabetes, Eritrea or Latin America and the Caribbean?
- Eritrea, at 27.3 against 14.7 in Latin America and the Caribbean as of 2021.
- What is the difference in mortality rate attributed to cardiovascular disease, cancer, diabetes between Eritrea and Latin America and the Caribbean?
- 12.6, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Latin America and the Caribbean?
- 7 years are reported by both, from 2000 to 2021.
- How do Eritrea and Latin America and the Caribbean rank globally for mortality rate attributed to cardiovascular disease, cancer, diabetes?
- Eritrea ranks 16th and Latin America and the Caribbean ranks 17th of 197 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease (probability). Statizoid refreshes it automatically from the source and publishes the full history for both places.